0 items USD 0.00Search
- Did you mean
- bruton’s tyrolit kinase
Your search for "Bruton's tyrosine kinase" gave back 53689 results.
Summary The Biologic Response Modifiers market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a CAGR of xx%. The...
Catalog:
HYR
February 2021
Price: USD 2,000.00
The global Kinase Inhibitor Small Molecule Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the...
Catalog:
GIR
July 2023
Price: USD 4,480.00
The global Kinase Inhibitor Small Molecule Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by...
Catalog:
GIR
July 2023
Price: USD 3,480.00
Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market is accounted for $1.91 billion in 2017 and is expected to reach $4.96 billion by...
Catalog:
Stratistics MRC
June 2019
Price: USD 4,150.00
The global Biologic Response Modifiers market will reach Volume Million USD in 2017 with CAGR xx% 2019-2023. The objective of report is to define,...
Catalog:
HYR
May 2022
Price: USD 2,020.00
Kinase inhibitors for cancer therapy are a class of drugs that are used to inhibit the activity of abnormal kinases, thereby interfering with the...
Catalog:
GIR
April 2024
Price: USD 3,480.00
The global Generation III EGFR Inhibitors market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030...
Catalog:
GIR
March 2024
Price: USD 3,480.00
Sunitinib Malate is the orally bioavailable malate salt of an indolinone-based tyrosine kinase inhibitor with potential antineoplastic activity...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
TrkC Antibody, also known as Neurotrophic Tyrosine Kinase Receptor Type 3 antibody, is a specific antibody used to detect and study TrkC protein (...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
The global Anti-VEGT Drugs market size was valued at US$ million in 2022. With growing demand in downstream market, the Anti-VEGT Drugs is forecast...
Catalog:
LPI
October 2023
Price: USD 3,660.00
The characterization of anaplastic lymphoma kinase (ALK) gene and their role in the development and progression of ALK positive cancer has...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Icotinib (trade name Conmana) is a highly selective, first generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI). Icotinib...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Icotinib (trade name Conmana) is a highly selective, first generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI). Icotinib...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Small molecule inhibitors that block the actions of protein kinases and the associated signaling pathways can thus have significant impact The “Small...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Anticancer drugs are medications used to treat cancer by targeting and killing cancer cells or inhibiting their growth. The global Anticancer Drugs...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
